» Articles » PMID: 31777665

The Epigenetic Legacy of Illicit Drugs: Developmental Exposures and Late-life Phenotypes

Overview
Date 2019 Nov 29
PMID 31777665
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of exposure to illicit drugs on adult offspring are a significant and widespread but understudied global health concern, particularly in light of the growing opioid epidemic and emerging therapeutic uses for cannabis, ketamine, and MDMA. Epigenetic mechanisms including DNA methylation, histone modifications, and expression of non-coding RNAs provide a mechanistic link between the prenatal environment and health consequences years beyond the original exposure, and shifts in the epigenome present in early life or adolescence can lead to disease states only appearing during adulthood. The current review summarizes the literature assessing effects of perinatal illicit drug exposure on adult disease phenotypes as mediated by perturbations of the epigenome. Both behavioral and somatic phenotypes are included and studies reporting clinical data in adult offspring, epigenetic readouts in offspring of any age, or both phenotypic and epigenetic measures are prioritized. Studies of licit substances of abuse (i.e. alcohol, nicotine) are excluded with a focus on cannabis, psychostimulants, opioids, and psychedelics; current issues in the field and areas of interest for further investigation are also discussed.

Citing Articles

Animal Models for Studying Developmental Origins of Cardiovascular-Kidney-Metabolic Syndrome.

Tain Y, Lin Y, Hsu C Biomedicines. 2025; 13(2).

PMID: 40002865 PMC: 11853432. DOI: 10.3390/biomedicines13020452.


How life events may confer vulnerability to addiction: the role of epigenetics.

Liu S, Harris A, Gewirtz J Front Mol Neurosci. 2024; 17:1462769.

PMID: 39359689 PMC: 11446245. DOI: 10.3389/fnmol.2024.1462769.


Prenatal cocaine exposure and its influence on pediatric epigenetic clocks and epigenetic scores in humans.

Viola T, Danzer C, Mardini V, Szobot C, Chrusciel J, Stertz L Sci Rep. 2024; 14(1):1946.

PMID: 38253635 PMC: 10803757. DOI: 10.1038/s41598-024-52433-5.


Editorial: Substance abuse and early development.

Bukiya A, Ali D Adv Drug Alcohol Res. 2023; 3.

PMID: 37581007 PMC: 10424723. DOI: 10.3389/adar.2023.11836.


Prenatal delta-9-tetrahydrocannabinol exposure is associated with changes in rhesus macaque DNA methylation enriched for autism genes.

Shorey-Kendrick L, Roberts V, DMello R, Sullivan E, Murphy S, McCarty O Clin Epigenetics. 2023; 15(1):104.

PMID: 37415206 PMC: 10324248. DOI: 10.1186/s13148-023-01519-4.


References
1.
McLaughlin P, Mactier H, Gillis C, Hickish T, Parker A, Liang W . Increased DNA Methylation of ABCB1, CYP2D6, and OPRM1 Genes in Newborn Infants of Methadone-Maintained Opioid-Dependent Mothers. J Pediatr. 2017; 190:180-184.e1. DOI: 10.1016/j.jpeds.2017.07.026. View

2.
Martin A, Chao L . Semantic memory and the brain: structure and processes. Curr Opin Neurobiol. 2001; 11(2):194-201. DOI: 10.1016/s0959-4388(00)00196-3. View

3.
Bergamaschi M, Queiroz R, Chagas M, de Oliveira D, De Martinis B, Kapczinski F . Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology. 2011; 36(6):1219-26. PMC: 3079847. DOI: 10.1038/npp.2011.6. View

4.
Horvath S, Raj K . DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat Rev Genet. 2018; 19(6):371-384. DOI: 10.1038/s41576-018-0004-3. View

5.
Lea A, Tung J, Archie E, Alberts S . Developmental plasticity: Bridging research in evolution and human health. Evol Med Public Health. 2018; 2017(1):162-175. PMC: 5798083. DOI: 10.1093/emph/eox019. View